Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New nonestrogenic inhibitors of human steroid sulfatase synthesized at Theramex

June 19, 2003

Metvix label extension recommended in Australia

June 19, 2003

Severe oral mucositis in cancer patients improved by rHuKGF

June 19, 2003

Preclinical antitumor activity of AP-23573 characterized at ASCO meeting

June 18, 2003

Trisenox NDA submitted in Japan

June 18, 2003

Xyotax granted fast track status for advanced NSCLC

June 18, 2003

New phase II study evaluates Dacogen in combination with Gleevec for CML

June 18, 2003

EMEA expands Zometa labeling

June 17, 2003

Positive phase I results for EOquin support initiation of phase II testing

June 17, 2003

Schering AG claims new antiandrogen agents for prostate cancer and other uses

June 17, 2003

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...